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Introduction
FINDRISC (Finnish Diabetes Risk Score) is a risk assess-
ment tool widely used for the prediction of the development
of type 2 diabetes (T2DM), combining a questionnaire with
simple anthropometric measurements to identify patients at
risk of developing diabetes, with increasing score (0-26) sig-
nifying increased risk. A cut off score of 9 has previously
been proposed (with drug-treated DM as the endpoint)
with a positive predictive value (PPV) of 0.12 and negative
predictive value (NPV) of 0.99, area under receiver operat-
ing characteristic curve (AuROC)=0.80. It has been well
validated in the general population.
Methods
We examined its use in predicting progression to pre-dia-
betes/diabetes in a cohort of Caucasian patients with a his-
tory of gestational diabetes mellitus (GDM). 116 women
with a history of GDM underwent screening 1-5 years
post-index pregnancy. Those with a history of persistent
post-partum dysglycaemia had fasting glucose levels taken,
while others underwent a 75g OGTT.
Results
Of the 116 women with a history of GDM, 83 showed
normal glucose tolerance (NGT) post-partum (71.6%).
22 patients had abnormal OGTT at 12 weeks (18.9%). A
further 11 patients (9.5%) had pre-diabetes/diabetes at
rescreening. The FINDRISC score was higher in patients
with pre-diabetes/diabetes than those with NGT post
partum (mean score 13.6+/- 4.1 vs. 11.0+/- 3.7, p<0.01).
For a cut-off score of 9, PPV was 0.30, NPV was 0.79,
AuROC=0.69, comparable with published data in the
general population.
Conclusions
This study shows the validity of an inexpensive, conveni-
ent risk score in helping to determine which patients may
need more frequent screening post GDM.
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